DHA IPM 16-001 - MHS Drug Take Back (DTB)

Describes procedures for MHS organizations to offer beneficiaries the option of returning their controlled and non-controlled prescriptions and over-the-counter medications for disposal through a DTB program.

• Identification #: 16-001
• Date: 6/13/2016
• Type: DHA Interim Procedures Memorandum
• Topics: TRICARE Pharmacy Program, Drug Take Back Program

Guidance for the 2016-2017 Annual Influenza Immunization Program

• Identification #: N/A
• Date: 6/9/2016
• Type: Memorandums
• Topics: Influenza Seasonal

DoDI 6040.42: Management Standards for Medical Coding of DoD Health Records

In accordance with the authority in DoD Directives 5124.02 and 5136.13, this issuance establishes policy, assigns responsibilities, and prescribes procedures for centralized oversight, standardized operations, and ensured quality and performance for the coding of DoD Health Records.

• Identification #: N/A
• Date: 6/8/2016
• Type: Directives
• Topics: Data Quality Management Control Program

DoD Retail Pricing Agreement

DoD Retail Pricing Agreement. This agreement is intended to validate acknowledgement of manufacturer responsibility to TRICARE.

• Identification #: N/A
• Date: 5/26/2016
• Type: Guidelines
• Topics: N/A

Trusted Care – Patient Centeredness Vision

This memorandum from the Air Force Surgeon General describes the "Patient Centeredness Vision" which encompasses the six aims of health care: safe, effective, patient centered, timely, efficient, and equitable.

• Identification #: N/A
• Date: 5/19/2016
• Type: Memorandums
• Topics: Access, Cost, Quality, and Safety, Patient Safety, Quality of Care

DoDI 6000.13: Accession and Retention Policies, Programs, and Incentives for Military Health Professions Officers (HPOs)

This instruction reissues DoD Instruction (DoDI) 6000.13 (Reference (a)) in accordance with the authority in DoD Directive (DoDD) 5124.02 (Reference (b)) to establish policy, assign responsibilities, and prescribe procedures for: a. Military Department payment of incentives and bonuses to HPOs pursuant to section 335 of Title 37, United States Code (U.S.C.) (Reference (c)). b. Incremental transition from current special pays and bonuses for HPOs pursuant to sections 301d, 301e, 302, 302a, 302b, 302c, 302c-1, 302d through 302l, 303, and 303a of Reference (c) to the incentives and bonuses authorized by section 335 of Reference (c). c. Deferral of retirement for Regular commissioned HPOs and retention of HPOs in an active status in the Reserve Component (RC) pursuant to sections 1251 and 14703 of Title 10, U.S.C. (Reference (d)). d. Incremental transition from the current procedures for stipend or loan repayment for RC HPOs in DoDD 1205.20 (Reference (e)) and DoDI 1205.21 (Reference (f)) to the procedures in this instruction.

• Identification #: DoDI 6000.13
• Date: 5/3/2016
• Type: Instructions
• Topics: N/A

DHA Technical Manual Number 7220.01 - CCAS Object Class Code Crosswalk

The object class code is a data element that captures what products and services are being procured. This document is intended to be accompany the DHA Technical Manual number 7220.01 - DHP CCAS Guidance.

• Identification #: 7220.01
• Date: 4/29/2016
• Type: Guidelines
• Topics: N/A

DHA Technical Manual Number 7220.01 - DHP Common Cost Accounting Structure (CCAS) Guidance

The Technical Manual establishes common structure and accounting practices for the budgetary and cost accounting field and will complement the programming and budgeting guidance that is currently prepared to assist the Service Medical Activities in the preparation and submission of their program objective memorandum.

• Identification #: 7220.01
• Date: 4/29/2016
• Type: Guidelines
• Topics: N/A

DoDI 6025.25: Drug Take Back Program

In accordance with the authority in DoD Directive 5124.02, establishes policy and assigns responsibilities for developing, publishing, and implementing procedural guidance for a Drug Take Back Program throughout the Military Health System, in accordance with Parts 1300-1321 of Title 21, Code of Federal Regulations, also known and referred to in this issuance as the “Controlled Substances Act.”

• Identification #: DoDI 6025.25
• Date: 4/26/2016
• Type: Instructions
• Topics: Drug Take Back Program

Patient Centered Practice Hours

This memorandum encourages Air Force military treatment facilities to establish more patient-centered clinic hours.

• Identification #: N/A
• Date: 4/20/2016
• Type: Memorandums
• Topics: Access, Cost, Quality, and Safety, Patient Satisfaction and Access, Access to Health Care

Management and Reporting of Clinical Adverse Actions and Professional Misconduct for Privileged Health Care Providers and Non-Privileged Clinical Support Staff

The purpose of this directive is to update and establish policy, assign responsibility, and prescribe procedures for the management and reporting of clinical adverse actions and professional misconduct for privileged health care providers and non-privileged clinical support staff for the Department of the Navy.

• Identification #: N/A
• Date: 4/15/2016
• Type: Directives
• Topics: Access, Cost, Quality, and Safety, Quality of Care, Patient Safety, Quality and Safety of Health Care, Clinical Quality Management

DoDI 6040.46: The Separation History and Physical Examination (SHPE) for the DoD Separation Health Assessment (SHA) Program

This issuance establishes policy and assigns responsibilities for completion of a SHPE as the principal component of the DoD-Department of Veterans Affairs (VA) SHA Program in compliance with Section 1145(a) of Title 10, U.S.C. and the 2013-2015 Joint Executive Committee Joint Strategic Plan.

• Identification #: DoDI 6040.46
• Date: 4/14/2016
• Type: Instructions
• Topics: DoD/VA Sharing Initiatives

Zika Virus Information for Department of Defense Medical Personnel

This memorandum provides information for Department of Defense (DoD) medical and force health protection personnel concerning prevention, diagnoses, and treatment of Zika virus infection. Implementation of this guidance is essential to protect the health of our DoD personnel located in, traveling to, or returning from areas with active transmission of Zika virus.

• Identification #: ASD(HA) Memorandum 16-002
• Date: 2/5/2016
• Type: Memorandums
• Topics: Zika Virus

Guidance Regarding Zika Dengue and Chikungunya Viruses

This guidance contains information about the potential for transfusion-transmitted Zika infection; recommends facilitating donor self-deferral of 28 days after travel to Mexico, the Caribbean, Central America and South America.

• Identification #: BPL 16-2
• Date: 2/3/2016
• Type: Memorandums
• Topics: Zika Virus, Armed Services Blood Program

Surgical Pause Standard Operating Procedure

The purpose of this memorandum is to provide guidance to perioperative personnel involved in surgical care including Labor and Delivery in conducting and documenting a Surgical Pause during invasive procedures.

• Identification #: N/A
• Date: 2/2/2016
• Type: Memorandums
• Topics: Access, Cost, Quality, and Safety, Patient Safety, Patient Safety